Back To Top

You have matched to 1 trial

Guest Profile:  No profile selected

Copy link
Sort by zip code: 94107 Hide Map Icon
mail-icon

Register to sign up for Trial Alerts

Receive emails about new trials that match your profile.
1

The Sarah Nanotechnology System for Metastatic Breast Cancer

Open Label Feasibility Dose Escalation Study to Evaluate the Safety of Sarah Nanotechnology System, With Alternating Magnetic Field (AMF) Application in Patients With Advanced Metastatic Solid Tumors.

Purpose: To study the safety, effects (good and bad), and anti-cancer activity of the Sarah Nanotechnology System.

Who is this for?: People with metastatic (stage IV) breast cancer that has spread within the torso and who have no standard treatment options available. View full eligibility criteria

What's involved?

<p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Nanoparticles, by IV</li> <li class="seamTextUnorderedListItem">Magnetic radiation treatment </li> <li class="seamTextUnorderedListItem">Blood tests</li> <li class="seamTextUnorderedListItem">ECG test</li> <li class="seamTextUnorderedListItem">CT scans, 2 times</li> <li class="seamTextUnorderedListItem">Brain MRI scan</li></ul>

What's being studied?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">For the Sarah Nanotechnology System, the participant receives an injection of nanoparticles that travel to the tumor through the bloodstream. The person is then placed in a machine that produces magnetic radiation that heats up the nanoparticles in the tumor, destroying the tumor while sparing healthy tissue.</li></ul>

How can I learn more?

<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07224464' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://newphase.co.il/' target='_blank'>New Phase: The Sarah Nanotechnology System</a> </li></ul>
1

The Sarah Nanotechnology System for Metastatic Breast Cancer

Open Label Feasibility Dose Escalation Study to Evaluate the Safety of Sarah Nanotechnology System, With Alternating Magnetic Field (AMF) Application in Patients With Advanced Metastatic Solid Tumors.
Icon

Nearest Location:
1615 miles
Mayo Clinic
Rochester, MN

Icon

Visits:
4 visits within 1 month, remote follow-up for up to 5 years

Icon

ClinicalTrials.gov: NCT07224464

Icon

Phase NA

HELP GUIDE